Table of Contents

Avery Dennison Launches Ultra-Small RFID Inlay for Medicine Management

Avery Dennison recently launched the ultra-small Minidose U8 RAIN RFID inlay for pharmaceutical industry. This is the first batch of products on the market that have obtained the ARC certification (Spec S) of Auburn University’s RFID laboratory and have been approved for use by DoseID. The Minidose U8 inlay has been carefully designed to combine performance, cost-effectiveness and dimension. It can be used in a variety of items, such as syringes, plastic bottles and glass bottles, and can be used in the packaging design of various medicines.

Minidose U8 is a UHF RFID product with a standard UHF RFID frequency band between 860MHz-960MHz. The size is very small, only 22x12mm, can be presented as wet inlay (with adhesive) and dry inlay (without adhesive), using NXP UCODE®️8 chip. Hal Hikita, Head of Product Line Management at Avery Dennison, said, “As the smallest product currently on the market that has passed ARC Spec S, Minidose U8 meets the needs of a variety of drug single-level packaging solutions. Even when filled with drugs and in the case of biological products, the inlay can also exert strong performance on transparent and amber glass, plastics and syringes, thereby embodying the important value of RFID for asset management in healthcare, pharmacies and laboratories.”

Avery Dennison Creative is an important RFID partner of Kit Check. Kit Check is a leading supplier of automated drug tracking and diversion detection solutions for American hospital pharmacies. Kit Check’s RFID inventory management solution helps hospitals realize the replenishment process automation to save unnecessary drug expenditures and ensure patient safety.

According to Kevin MacDonald, CEO and co-founder of Kit Check: “Since its inception, Kit Check has been cooperating with Avery Dennison to design and implement of RFID tag, and has achieved great success. We use the Kit Check solution for Countless medicines labeled so that the right medicine can be delivered to the right patient at the right time every time.”

Go to Top